Labat Africa (JSE:LAB) Other Operating Expense: R44.9 Mil (TTM As of Nov. 2025)


What is Labat Africa Other Operating Expense?

Labat Africa JSE:LAB Other Operating Expense is R44.9 Mil as of Nov. 2025. The stock has 5 warning signs investors should review.

Labat Africa's Other Operating Expense for the six months ended in Nov. 2025 was R1.9 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2025 was R44.9 Mil.

Labat Africa's quarterly Other Operating Expense increased from Nov. 2024 (R14.6 Mil) to May. 2025 (R43.0 Mil) but then declined from May. 2025 (R43.0 Mil) to Nov. 2025 (R1.9 Mil).

Labat Africa's annual Other Operating Expense declined from Aug. 2021 (R61.8 Mil) to May. 2023 (R58.2 Mil) and declined from May. 2023 (R58.2 Mil) to May. 2024 (R57.0 Mil).

Labat Africa Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Labat Africa's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa Other Operating Expense Chart

Labat Africa Annual Data
Trend Feb14 Feb15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 May23 May24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.90 49.92 61.79 58.24 57.04

Labat Africa Semi-Annual Data
Aug15 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.89 39.15 14.62 42.99 1.86

Labat Africa Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was R44.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of R44.9 Mil mean?
Labat Africa (JSE:LAB) has a Other Operating Expense of R44.9 Mil as of Nov. 2025. Other operating expenses that a company records on its income statement. View historical data on Labat Africa and its competitors.
Is Labat Africa's Other Operating Expense too high?
Labat Africa's current Other Operating Expense is R44.9 Mil.
How does Labat Africa's Other Operating Expense compare to ZTS and UTHR?
Labat Africa's Other Operating Expense of R44.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Labat Africa and its competitors. Labat Africa's current Other Operating Expense is R44.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current Other Operating Expense is R44.9 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current Other Operating Expense is R44.9 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.